Can Ficicioglu, MD,PhD
Can Ficicioglu, MD,PhD
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Division of Metabolism(Biochemical Genetics)
The Children's Hospital of Philadelphia
3501 Civic center blvd #9054.
Philadelphia, PA 19104
The Children's Hospital of Philadelphia
3501 Civic center blvd #9054.
Philadelphia, PA 19104
Office: 215 590 3376
Fax: 215 590 4297
Fax: 215 590 4297
Email:
Ficicioglu@email.chop.edu
Ficicioglu@email.chop.edu
Education:
MD
University of Istanbul, Cerrahpasa Medical School ( with High Honors), 1985.
PhD (Histology & Embryology)
University of Marmara, 1996.
Permanent linkMD
University of Istanbul, Cerrahpasa Medical School ( with High Honors), 1985.
PhD (Histology & Embryology)
University of Marmara, 1996.
Selected Publications
Ahrens-Nicklas RC,Serdaroglu E,Muraresku C,Ficicioglu C.: Cobalamin C disease missed by newborn screening in a patient with low carnitine level. JIMD Reports in press 2015..J. Bhoj, M. Li, R. Ahrens-Nicklas, L.C. Pyle, J. Wang, V.W. Zhang, C. Clarke, L.J. Wong, N. Sondheimer, C. Ficicioglu, M. Yudkoff: Pathologic Variants of the Mitochondrial Phosphate Carrier SLC25A3: Two New Patients and Expansion of the Cardiomyopathy/Skeletal Myopathy Phenotype With and Without Lactic Acidosis. JIMD reports in press 2015.
Longoa N, Arnold GL, Pridjian G, Enns GM, Ficicioglu C, Parker S, Cohen-Pfeffer JL.: Long-Term Safety and Efficacy of Sapropterin: the PKUDOS registry experience. Molecular Genetics and Metabolism in press 2015.
Aleman TS, Brodie F, Garvin C, Gewaily DY, Ficicioglu CH, Mills MD, Forbes BJ, Maguire AM, Davidson SL.: Retinal Structure in Cobalamin C Disease: Mechanistic and Therapeutic Implications. Ophthalmic Genet. February 2014
Chadwick S, Fitzgerald K, Weiss B, Ficicioglu C: Thirteen patients with MAT1A mutations detected through newborn screening: 13 years experience JIMD reports January 2014.
Tegtmeyer L, Rust S, van Scherpenzeel M, Bobby G. Ng BG, Losfeld ME, Timal S, Raymond K, He P, Ichikawa M, Veltman J, Huijben K, Shin YS, Sharma V, Adamowicz M, Lammens M, Reunert J, Witten A, Schrapers E, Matthijs G, Jaeken J, Rymen D, Stojkovic T, Pascal Laforêt P, Petit P, Aumaître O, Czarnowska E, Piraud M, Podskarbi T, Stanley CA, Matalon R, Burda P, Seyyedi S, Debus V, Socha P, Sykut-Cegielska J, van Spronsen F, de Meirleir L, Vajro P, DeClue T, Ficicioglu C, Wada Y, Wevers RA, Vanderschaeghe D, Callewaert N, Fingerhut R, van Schaftingen E, Freeze HH, Morava E, Lefeber DJ, Marquardt T.: Multiple Phenotypes in Phosphoglucomutase 1 Deficiency. N Engl J Med (370), 533-542, 2014.
D’Aco KE,Bearden D,Watkins D,Hyland K,Rosenblatt D,Ficicioglu C: Severe 5,10-Methylenetetrahydrofolate Reductase Deficiency and 2 MTHFR Variants in an Adolescent with Progressive Myoclonic Epilepsy. Pediatric Neurology 2014.
Coughlin CR, Hyland K,Randall R,Ficicioglu C: Dihydropteridine reductase deficiency and treatment with tetrahydrobiopterin: A case report. JIMD reports 10: 53-6, 2013
Ficicioglu C, Dubroff JG, Thomas N , Gallagher PR, Burfield J, Hussa C. Randall R. Zhuang H: A pilot study of fluorodeoxyglucose positron emission tomography findings in patients with phenylketonuria before and during sapropterin supplementation. Journal of Clinical Neurology 9(3): 151-6, 2013.
Hazard FK, Ficicioglu CH, Ganesh J, Ruchelli ED. : Liver pathology in infantile mitochondrial DNA depletion syndrome. Pediatr Dev Pathol 16(6): 415-24, 2013.